1. Home
  2. SSRM vs CRSP Comparison

SSRM vs CRSP Comparison

Compare SSRM & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SSR Mining Inc.

SSRM

SSR Mining Inc.

N/A

Current Price

$33.42

Market Cap

6.5B

Sector

Industrials

ML Signal

N/A

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$55.44

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSRM
CRSP
Founded
1946
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.8B
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
SSRM
CRSP
Price
$33.42
$55.44
Analyst Decision
Strong Buy
Buy
Analyst Count
10
22
Target Price
$42.40
★ $87.56
AVG Volume (30 Days)
★ 1.9M
1.3M
Earning Date
11-03-2026
11-09-2026
Dividend Yield
★ 0.09%
N/A
EPS Growth
★ 243.41
N/A
EPS
★ N/A
N/A
Revenue
★ $1,629,637,000.00
$289,590,000.00
Revenue This Year
$41.24
$1,063.30
Revenue Next Year
$16.20
$283.48
P/E Ratio
★ N/A
N/A
Revenue Growth
63.68
★ 9169.85
52 Week Low
$18.19
$44.12
52 Week High
$39.44
$78.48

Technical Indicators

Market Signals
Indicator
SSRM
CRSP
Relative Strength Index (RSI) 40.65 52.39
Support Level $28.41 $50.56
Resistance Level $33.66 $60.04
Average True Range (ATR) 1.15 2.83
MACD -0.58 -0.03
Stochastic Oscillator 4.81 51.06

Price Performance

Historical Comparison
SSRM
CRSP

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: